Dark Horse Consulting

Dark Horse Consulting Group is a US-based, private consulting firm founded in 2012 (with conflicting data suggesting 2014) and headquartered in Boulder, Colorado. It has established itself as a key service provider in the high-growth biotherapeutics sector, particularly in cell and gene therapy, by offering end-to-end development consulting. The company's model leverages a deep bench of hand-picked industry experts and has expanded through strategic additions like BioTechLogic for CMC/manufacturing and Converge Consulting for strategy and operations. DHC is a revenue-generating services business that capitalizes on the technical and regulatory complexities of modern drug development.

Integrated consulting services platform combining strategic, technical, CMC, regulatory, and operational expertise for biotherapeutics development, with a focus on cell & gene therapy, biologics, and regenerative medicine.

DHC competes in the life sciences consulting space against large global firms (e.g., McKinsey, Deloitte) with broad resources, and against numerous specialized boutique firms focusing on regulatory, CMC, or clinical strategy. Its key differentiation is its integrated, end-to-end focus specifically on the most complex biotherapeutic modalities (CGT, regenerative medicine), combining deep scientific expertise with practical execution capabilities through its multi-division structure.